Castleark Management LLC Bio Techne Corp Transaction History

Castleark Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$62.12 - $84.15 $416,825 - $564,646	6,710 New	6,710 $480,000
Q3 2023 Nov 15, 2023	BUY	$67.52 - $89.42 $316,668 - $419,379	4,690 New	4,690 $319,000
Q3 2018 Nov 15, 2018	SELL	$147.44 - $204.11 $4.05 Million - $5.61 Million	-27,465 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$144.9 - $165.58 $11.8 Million - $13.5 Million	-81,440 Reduced 74.78%	27,465 $4.06 Million
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $8.62 Million - $9.91 Million	65,590 Added 151.43%	108,905 $16.4 Million
Q4 2017 Feb 15, 2018	BUY	$121.17 - $134.75 $9,087 - $10,106	75 Added 0.17%	43,315 $5.61 Million
Q3 2017 Nov 15, 2017	BUY	$113.59 - $123.78 $4.91 Million - $5.35 Million	43,240	43,240 $5.23 Million

616

156M

200K

15.3K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.59B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.